Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
To assess the efficacy and safety of THDBH120 injection compared with placebo in weight reduction in overweight or obese subjects after 26 weeks of treatment.
Male or female patients 18 to 75 years of age, inclusive; [+2]
History of diabetes; [+3]